(Q34677725)

3 August 2017

1 reference

title

Acute myeloid leukemia in adults (English)

1 reference

3 August 2017

1 reference

acute myeloid leukemia

1 reference

Cripe LD

1

1 reference

3 August 2017

Hinton S

series ordinal

2

1 reference

3 August 2017

publication date

1 April 2000

1 reference

Current Treatment Options in Oncology

3 August 2017

published in

1 reference

3 August 2017

volume

1

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

9-17

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-000-0011-3

3 August 2017

exact match

0 references

cites work

Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: a review and updated results of the Australian Leukemia Study Group

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-000-0011-3

A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study

21 January 2018

1 reference

12 December 2020

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

12 December 2020

Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marro

1 reference

12 December 2020

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

12 December 2020

High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency

1 reference

12 December 2020

Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia

1 reference

12 December 2020

Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

1 reference

12 December 2020

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

12 December 2020

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

1 reference

12 December 2020

Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission

1 reference

12 December 2020

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

12 December 2020

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

12 December 2020

Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group

1 reference

12 December 2020

Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison

1 reference

12 December 2020

Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 study

1 reference

12 December 2020

A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group Study

1 reference

12 December 2020

Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management

1 reference

12 December 2020

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia

1 reference

12 December 2020

Chemotherapy versus transplants for acute myelogenous leukemia in second remission

1 reference

12 December 2020

Improved survival for patients with acute myelogenous leukemia

1 reference

12 December 2020

A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia. AML Collaborative Group

1 reference

12 December 2020

Hematopoietic growth factors as adjuncts to the treatment of acute myeloid leukemia

1 reference

12 December 2020

10.1007/S11864-000-0011-3

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1000454988

0 references

1 reference